Loading…
Lobbying Spend
—
Filings
37
Firms Hired
1
Active Period
2008–2015
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
American Middle Class Tax (AMT) Relief Act of 2007
2010 · first_quarter · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed test; seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 3590
American Middle Class Tax (AMT) Relief Act of 2007
2010 · first_quarter · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 3590
American Middle Class Tax (AMT) Relief Act of 2007
2010 · first_quarter · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 3590
Patient Access to Critical Lab Tests Act
2010 · first_quarter · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1699
Patient Access to Critical Lab Tests Act
2010 · first_quarter · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1699
Patient Access to Critical Lab Tests Act
2010 · first_quarter · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed test; seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1699
Patient Access to Critical Lab Tests Act
2010 · first_quarter · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
Client expense: — · Firm income: $20,000
Matched citations: S. 1220
Patient Access to Critical Lab Tests Act
2010 · first_quarter · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
Client expense: — · Firm income: $20,000
Matched citations: S. 1220
Patient Access to Critical Lab Tests Act
2010 · first_quarter · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed test; seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
Client expense: — · Firm income: $20,000
Matched citations: S. 1220
Patient Access to Critical Lab Tests Act
2009 · fourth_quarter · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed test; seeking to advance H.R. 1699 and S. 1220.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1699
Patient Access to Critical Lab Tests Act
2009 · fourth_quarter · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699 and S. 1220.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1699
Patient Access to Critical Lab Tests Act
2009 · fourth_quarter · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699 and S. 1220.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1699
Patient Access to Critical Lab Tests Act
2009 · fourth_quarter · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed test; seeking to advance H.R. 1699 and S. 1220.
Client expense: — · Firm income: $60,000
Matched citations: S. 1220
Patient Access to Critical Lab Tests Act
2009 · fourth_quarter · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699 and S. 1220.
Client expense: — · Firm income: $60,000
Matched citations: S. 1220
Patient Access to Critical Lab Tests Act
2009 · fourth_quarter · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699 and S. 1220.
Client expense: — · Firm income: $60,000
Matched citations: S. 1220
Patient Access to Critical Lab Tests Act
2009 · third_quarter · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed test; seeking to advance H.R. 1699 and S. 1220.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1699
Patient Access to Critical Lab Tests Act
2009 · third_quarter · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699 and S. 1220.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1699
Patient Access to Critical Lab Tests Act
2009 · third_quarter · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699 and S. 1220.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1699
Patient Access to Critical Lab Tests Act
2009 · third_quarter · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed test; seeking to advance H.R. 1699 and S. 1220.
Client expense: — · Firm income: $60,000
Matched citations: S. 1220
Patient Access to Critical Lab Tests Act
2009 · third_quarter · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699 and S. 1220.
Client expense: — · Firm income: $60,000
Matched citations: S. 1220
Patient Access to Critical Lab Tests Act
2009 · third_quarter · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699 and S. 1220.
Client expense: — · Firm income: $60,000
Matched citations: S. 1220
Patient Access to Critical Lab Tests Act
2009 · second_quarter · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699 and S. 1220.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1699
Patient Access to Critical Lab Tests Act
2009 · second_quarter · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed test; seeking to advance H.R. 1699 and S. 1220.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1699
Patient Access to Critical Lab Tests Act
2009 · second_quarter · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699 and S. 1220.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1699
Patient Access to Critical Lab Tests Act
2009 · second_quarter · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed test; seeking to advance H.R. 1699 and S. 1220.
Client expense: — · Firm income: $60,000
Matched citations: S. 1220
Source: Senate LDA